ANNE SMITS: Open Payments
NPI 1720310956 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 39 payments from 29 companies in 2025. Trend: 2023 $1,281 · 2024 $1,643 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $90 |
| SANOFI US SERVICES INC. | 1 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| PharmaEssentia USA Corporation | 2 | $50 |
| ABBVIE INC. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Incyte Corporation | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Novo Nordisk Inc | 1 | $28 |
Products named: IBRANCE, SARCLISA, BESREMI, KEYTRUDA, Enhertu, JEMPERLI, KISQALI, Ozempic.
Industry payments across MS — which companies pay providers there.
